How BioNTech, Up 25% Over Four Days, Is Riding Summit's Coattails To A RecoveryInvestors Business Daily • Tuesday
BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024GlobeNewsWire • Tuesday
BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024GlobeNewsWire • 09/05/24
FDA approves new updated COVID-19 vaccines to target KP.2 variant. Here's what to knowFast Company • 08/23/24
Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 VaccineBusiness Wire • 08/22/24
Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its MarkInvestors Business Daily • 08/16/24
Pfizer, BioNtech say combined flu-COVID vaccine misses a main goal of Phase 3 trialReuters • 08/16/24
Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18-64 Years of AgeBusiness Wire • 08/16/24
BioNTech Q2 Earnings Review: No Needle-Moving Catalysts Despite Oncology PromiseSeeking Alpha • 08/06/24